'Blotting systems' presentation slideshows

Medical aesthetics market worth 13.29 billion usd by 2021

This report studies the global medical aesthetics market over the forecast period of 2016 to 2021. The market is expected to reach USD 13.29 Billion by 2021, at CAGR of 10.8% from 2016 to 2021. A number of factors such as increasing inclination towards minimally invasive and non-invasive aesthetic procedures, rising demand for aesthetic treatments among the male population, and rapid growth in number of cosmetic procedures are driving the growth of the global medical aesthetics market. On the other hand, stringent safety regulations for aesthetic procedures and low focus of market players on development of medical aesthetic devices for dermatological conditions are restricting the growth of the global medical aesthetics market. The report covers nine major product types- energy-based devices, breast implants, facial aesthetics, tattoo removal devices, physician-dispensed cosmeceuticals and skin lighteners, thread lifting, physician-dispensed eyelash products, laser resurfacing devices, and laser hair removal devices. The energy-based devices segment is categorized into skin tightening and body shaping, liposuction devices, cellulite reduction devices and non-invasive fat reduction devices. The breast implants segment is classified into silicone breast implants, saline breast implants, and cohesive semi-solid gel implants. The facial aesthetics segment is also categorized botulinum toxin (BOTOX), chemical peels, microdermabrasion, and dermal fillers. Physician dispensed cosmeceuticals segment is expected to grow at the highest CAGR, mainly due to increasing aging population coupled with rising demand for anti-aging products to treat wrinkles and visible signs of aging, Based on end-users, the global medical aesthetics market is categorized into two major segments, namely, clinics plus medical spas and beauty centers. The clinics and medical spas segment is expected to account for the larger share of the global medical aesthetic market in 2016 and grow at the higher CAGR during the forecast period. This can be attributed to the growing number of clinics and medical spas and increasing number of skilled professionals to perform the aesthetic procedures. In 2016, North America is expected to hold the largest share of the global medical aesthetic market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR from 2016 to 2021. A number of factors, such as growing number of aesthetic procedures, rising middle class with growing purchasing power , rising medical tourism, and increasing focus of global players is driving the growth of Asia-Pacific market. Allergan, Inc. (Ireland), Cynosure, Inc. (U.S.), Lumenis Ltd. (Israel), Mentor Worldwide LLC (U.S PhotoMedex, Inc. (U.S.), Solta Medical, Inc. (U.S), Syneron Medical, Ltd. (Israel), Galderma S.A. (Switzerland), and ZELTIQ Aesthetics, Inc. (U.S.) are some of the main players in the global medical aesthetics market.

137 views • 11 slides

Technology advancement in medical aesthetics market

This report studies the global medical aesthetics market over the forecast period of 2016 to 2021. The market is expected to reach USD 13.29 Billion by 2021, at CAGR of 10.8% from 2016 to 2021. A number of factors such as increasing inclination towards minimally invasive and non-invasive aesthetic procedures, rising demand for aesthetic treatments among the male population, and rapid growth in number of cosmetic procedures are driving the growth of the global medical aesthetics market. On the other hand, stringent safety regulations for aesthetic procedures and low focus of market players on development of medical aesthetic devices for dermatological conditions are restricting the growth of the global medical aesthetics market. The report covers nine major product types- energy-based devices, breast implants, facial aesthetics, tattoo removal devices, physician-dispensed cosmeceuticals and skin lighteners, thread lifting, physician-dispensed eyelash products, laser resurfacing devices, and laser hair removal devices. The energy-based devices segment is categorized into skin tightening and body shaping, liposuction devices, cellulite reduction devices and non-invasive fat reduction devices. The breast implants segment is classified into silicone breast implants, saline breast implants, and cohesive semi-solid gel implants. The facial aesthetics segment is also categorized botulinum toxin (BOTOX), chemical peels, microdermabrasion, and dermal fillers. Physician dispensed cosmeceuticals segment is expected to grow at the highest CAGR, mainly due to increasing aging population coupled with rising demand for anti-aging products to treat wrinkles and visible signs of aging, Based on end-users, the global medical aesthetics market is categorized into two major segments, namely, clinics plus medical spas and beauty centers. The clinics and medical spas segment is expected to account for the larger share of the global medical aesthetic market in 2016 and grow at the higher CAGR during the forecast period. This can be attributed to the growing number of clinics and medical spas and increasing number of skilled professionals to perform the aesthetic procedures. In 2016, North America is expected to hold the largest share of the global medical aesthetic market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR from 2016 to 2021. A number of factors, such as growing number of aesthetic procedures, rising middle class with growing purchasing power , rising medical tourism, and increasing focus of global players is driving the growth of Asia-Pacific market. Allergan, Inc. (Ireland), Cynosure, Inc. (U.S.), Lumenis Ltd. (Israel), Mentor Worldwide LLC (U.S PhotoMedex, Inc. (U.S.), Solta Medical, Inc. (U.S), Syneron Medical, Ltd. (Israel), Galderma S.A. (Switzerland), and ZELTIQ Aesthetics, Inc. (U.S.) are some of the main players in the global medical aesthetics market.

164 views • 11 slides

Detailed Qualitative & Quantitative Analysis Medical Aesthetics Market

Medical aesthetics devices are used to improve the cosmetic appearance through the treatment of conditions such as liver spots, excess fat, scars, skin laxity, wrinkles, moles, cellulite, unwanted hair, spider veins, and skin discoloration. The global Medical aesthetics market is estimated to grow at a CAGR of 10.8% from 2016 to 2021 to reach USD 13.29 Billion by 2021. Key factors such as the growing adoption of non-invasive procedures, growth in aging population, increasing awareness among customers, technological advancements in energy-based medical aesthetics devices, and increasing demand for aesthetic treatments among the male population are driving the growth of the aesthetic devices market. However, stringent safety regulations for aesthetic procedures, social stigma associated with cosmetic treatments, and low focus of market players on developing medical aesthetic devices for dermatological conditions are restraining the growth of this market. Based on product, the medical aesthetics market is categorized into energy-based devices, breast implants, facial aesthetics, tattoo removal, physician-dispensed cosmeceuticals and skin lighteners, physician-dispensed eyelash products, thread lifting, laser resurfacing devices, and laser hair removal. The facial aesthetics segment is expected to account for the largest share of the medical aesthetics market in 2016. The large share of this segment can be attributed to the growing patient demand for facial aesthetic treatments, increasing demand of non-invasive cosmetic procedures, launch of new products, and growth in aging population. On the basis of end user, the market is segmented into clinics plus medical spas and beauty centres. The clinics and medical spas segment is estimated to register the higher CAGR from 2016 to 2021. The high growth of this segment is primarily attributed to the growing number of clinics and medical spas and increasing number of skilled professionals to perform the aesthetic procedures, rapidly increasing aging and obese population across the globe, increasing preference for minimally invasive and non-invasive aesthetic procedures. In 2016, North America is expected to account for the largest share of the global medical aesthetics market, followed by Europe. The Asia-Pacific market is projected to grow at the highest CAGR during the forecast period, owning to key factors such as rising consumer awareness and interest in aesthetic procedures, aggressive marketing by leading U.S. and European companies, and rising medical tourism in the region. Over the past three years, a number of market players, including Cynosure, Inc. (U.S.), Syneron Medical Ltd. (Israel), Allergan, Inc. (U.S.), and Galderma S.A. (Switzerland) have strategically expanded their presence in emerging Asia-Pacific countries to leverage the high growth potential in the region.

138 views • 11 slides

Western Blotting Market worth $730.7 Million by 2021

115 views • 9 slides

Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and GE Healthcare (U.S.).in the Western Blotti

This report studies the global western blotting market for the forecast period of 2016 to 2021. This market is expected to reach USD 730.7 Million by 2021 from USD 574.8 Million in 2016, growing at a CAGR of 4.9 %. The global western blotting market is segmented on the basis of product, application, end user and region. Get 10% Free Customization on this Reports @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=235810711

105 views • 9 slides